Shailesh Singh to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Shailesh Singh has written about Drug Resistance, Neoplasm.
Connection Strength
1.217
-
Singh S, Weindorfer C, Nandi A, Panneer Selvam C, Mendes G?tze M, Das M, Falaschini A, Tjendra Y, Boone MM, Dolznig H, Zhang Q, Clarke R, Thomas C, Chakrabarti R. DLL1-responsive PD-L1+ tumor-associated macrophages promote endocrine resistance in breast cancer. Sci Transl Med. 2025 Nov 05; 17(823):eadr6207.
Score: 0.768
-
Johnson-Holiday C, Singh R, Johnson EL, Grizzle WE, Lillard JW, Singh S. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion. World J Surg Oncol. 2011 May 03; 9:46.
Score: 0.281
-
Kapur N, Mir H, Sonpavde GP, Jain S, Bae S, Lillard JW, Singh S. Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel. Cancer Lett. 2019 07 10; 454:1-13.
Score: 0.122
-
Muralidharan J, Eswaran M, Bae S, Singh S, Mir H. Elevated CCL20 and IL-10 enhance 5-fluorouracil tolerance in colon cancer. Biomed Pharmacother. 2025 Aug; 189:118258.
Score: 0.047